Term
Tissue Factor
Other names?
Where does it come from?
TF + what starts cascade |
|
Definition
*Tissue Factor = Factor 3, thromboplastin
Exposed at site of injury, from endothelial cells
TF + Factor 7 initiate coagulation cascade → thrombin generation
|
|
|
Term
Thrombin
&
Fibrin
&
Factor XIII
|
|
Definition
Cleaves fibrinogen into soluble fibrin,
Fibrin polyermization → more platelet recruitment and activation (secondary hemostatis)
Factor 13 cross links fibrin molecules
|
|
|
Term
Endothelium Anti-platelet Effects
(released by endothelium) |
|
Definition
Prostacyclin and nitric oxide impede platelet adhesion
Adenosine disphosphatase degrades ADP(therefore inhibiting aggregation)
|
|
|
Term
Heparin-like molcules
&
Thrombomodulin
|
|
Definition
Heparin-like molecules bind and activate antithrombin III
Antithrombin III inactivates thrombin, 9a, 10a
Thrombomodulin upon binding thrombin activates protein C
Protein C inactivates factors 5 and 8.
(Protein S produced by endothelium is co-factor) |
|
|
Term
t-PA
&
Plasmin
&
α2 plasmin inhibitor
|
|
Definition
t-PA(tissue plasmin activator) from endothelium
t-PA is most active when bound to fibrin
Cleaves plasminogen → Plasmin
Plasmin cleaves fibrin to degrade thrombi & other coagulation factors
α2 plasmin inhibitor prevents plasmin activity in areas away from damage |
|
|
Term
Platelets
α-Granules
Dense Granules
What triggers their release? |
|
Definition
α-Granules
Fibrinogen, Fibronectin
Factors 5,13 PDGF, TGF-B
Dense granules
ADP, ATP
Ca++, Histamine, Serotonin, Epinephrine
Change shape and release granules upon binding c ollagen or vWF |
|
|
Term
|
Definition
Gp1B is a platelet glycoprotein.
vWF binds collagen and Gp1B(platelet adhesion)
Bernard-soulier syndrome is defect
prolonged bleeding time & decreased platelets
|
|
|
Term
GpIIb-IIa
What is it?
Disease from mutation? |
|
Definition
GpIIb-IIa: platelet surface receptor
binds fibrinogen(aggregation, links platelets)
Glanzmann thrombasthenia is defect
Prolonged bleeding time |
|
|
Term
Platelet Aggregation
What compounds amplify it?
What Drug is used to stop it and how? |
|
Definition
ADP, thromboxane A2, and thrombin cause more aggregation of platelets.
ADP activates platelets → conformational change in GpIIb-IIa receptors
Allows GpIIb-IIa to bind fibrinogen
Clopidogrel(plavix) blocks ADP binding(stops fibrinogen cross linking)
|
|
|
Term
PGI2
vs
TxA2
what are they released from?
what do they do?
Aspirins effect? |
|
Definition
PGI2(prostacyclin)
Vasodilator & inhibits platelet aggregation
From endothelial cells & Aspirin has little effect as endothelial cells can make new cyclooxygenase
TxA2
Activates platelet aggregation & Vasoconstrictor
Aspirin blocks in synthesis in platelets
|
|
|
Term
Vitamin K depedent Cofactors
Which factors?
What is Vitamin K required for?
What Drug blocks this reaction? |
|
Definition
Factors 2(prothrombin),7, 9, 10, & protein C are vitamin K dependent
Vitamin K is required for adding γ-carboxyl groups to glutamic acid residues on these factors. Allows binding of Ca++
Coumadin(warfarin) blocks this. |
|
|
Term
aPTT test What pathway does it test?
Which therapy is it used to evaulate? |
|
Definition
Evaulates 12,11, 9, 8, 10, 5, 2, 1
Intrinsic pathway Common pathway
Used for evaluating heparin therapy
(FYI, Blood sample taken, citrate added(sequesters Ca) which prevents clotting. Excess calcium added along with silica to start cascade) |
|
|
Term
PT test
What pathway does it test?
What therapy is monitered with it? |
|
Definition
Factors 7, 10, V, II, and I(fibrinogen)
Extrinsic pathway. (tissue factor added to sample)
Evaulates coumadin therapy
|
|
|
Term
TT test
What does it evaulate? |
|
Definition
Evaulates fibrinogen.
Prolonged time with low or abnormal fibrinogen
can be used toe evaluate heparin therapy but PTT more common |
|
|
Term
Vit K defiency or Warfarin therapy
Effect on PT & PTT & platelets |
|
Definition
Prolonged PT & PTT.
Platelets normal
Both pathways have vitamin K dependent factors(2,7,9,10)
|
|
|
Term
DIC & Liver Failure
Effect on PT & PTT & platelets
|
|
Definition
Prolonged PT & PTT
Decreased Platelets
DIC results from consumption of clotting factors which leads to destruction of platelets
Liver produces clotting factors. |
|
|
Term
Hemophillia
Effect on PT & PTT & platelets |
|
Definition
Prolonged PTT
Everything else normal
Muations in Instrinsic pathway
Hemophilia A = Factor 8 deficiency
Hemophilia B = Factor 9 deficiency |
|
|
Term
Fibrinogen Split Products(FSPs)
Which kind of FPS can be used for diagnosis?
What are they signs of? |
|
Definition
D-dimers of FSPs are used in diagnosing
DIC
DVT(deep vein thrombosis)
Pulmonary Embolism |
|
|